Atsuhiro Ichihara

9.1k total citations
228 papers, 6.7k citations indexed

About

Atsuhiro Ichihara is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Atsuhiro Ichihara has authored 228 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Cardiology and Cardiovascular Medicine, 111 papers in Endocrinology, Diabetes and Metabolism and 71 papers in Molecular Biology. Recurrent topics in Atsuhiro Ichihara's work include Hormonal Regulation and Hypertension (92 papers), Renin-Angiotensin System Studies (79 papers) and Receptor Mechanisms and Signaling (38 papers). Atsuhiro Ichihara is often cited by papers focused on Hormonal Regulation and Hypertension (92 papers), Renin-Angiotensin System Studies (79 papers) and Receptor Mechanisms and Signaling (38 papers). Atsuhiro Ichihara collaborates with scholars based in Japan, United States and United Kingdom. Atsuhiro Ichihara's co-authors include Yuki Kaneshiro, Mariyo Sakoda, Matsuhiko Hayashi, Akira Nishiyama, Tomoko Takemitsu, Hiroshi Itoh, Tsutomu Nakagawa, Tadashi Inagami, L. Gabriel Navar and Fumiaki Suzuki and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Neuroscience.

In The Last Decade

Atsuhiro Ichihara

216 papers receiving 6.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Atsuhiro Ichihara Japan	46	4.2k	3.2k	2.2k	1.1k	675	228	6.7k
Tomohiro Katsuya Japan	44	3.0k 0.7×	2.1k 0.7×	1.8k 0.8×	671 0.6×	1.2k 1.8×	171	6.8k
Shigehiro Katayama Japan	45	1.8k 0.4×	2.5k 0.8×	2.7k 1.2×	1.2k 1.1×	1.1k 1.6×	224	8.2k
Duncan J. Campbell Australia	48	4.5k 1.1×	2.2k 0.7×	2.8k 1.3×	1.3k 1.2×	965 1.4×	172	8.3k
Kevin D. Burns Canada	42	2.4k 0.6×	1.7k 0.5×	2.0k 0.9×	657 0.6×	835 1.2×	160	6.0k
Hiroyuki Kobori United States	57	6.2k 1.5×	5.1k 1.6×	2.3k 1.1×	865 0.8×	864 1.3×	178	10.0k
Karl F. Hilgers Germany	41	2.5k 0.6×	1.4k 0.5×	1.3k 0.6×	597 0.6×	1.0k 1.5×	165	5.6k
Susan B. Gurley United States	35	2.2k 0.5×	1.7k 0.5×	1.6k 0.7×	617 0.6×	461 0.7×	85	5.2k
Satoshi Umemura Japan	51	5.7k 1.3×	2.1k 0.7×	2.3k 1.1×	2.7k 2.5×	1.1k 1.6×	434	10.6k
James W. Scholey Canada	46	3.0k 0.7×	2.2k 0.7×	2.1k 0.9×	792 0.7×	524 0.8×	135	8.3k
Óscar Lorenzo Spain	42	2.3k 0.6×	1.2k 0.4×	2.4k 1.1×	802 0.7×	602 0.9×	110	6.3k

Countries citing papers authored by Atsuhiro Ichihara

Since Specialization

Citations

This map shows the geographic impact of Atsuhiro Ichihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsuhiro Ichihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsuhiro Ichihara more than expected).

Fields of papers citing papers by Atsuhiro Ichihara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsuhiro Ichihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsuhiro Ichihara. The network helps show where Atsuhiro Ichihara may publish in the future.

Co-authorship network of co-authors of Atsuhiro Ichihara

This figure shows the co-authorship network connecting the top 25 collaborators of Atsuhiro Ichihara. A scholar is included among the top collaborators of Atsuhiro Ichihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsuhiro Ichihara. Atsuhiro Ichihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Morimoto, Satoshi, et al.. (2025). Reduced high-sensitivity C-reactive protein levels following weekly somapacitan in adults with growth hormone deficiency: a prospective pilot study. Journal of Endocrinological Investigation. 48(11). 2633–2641.

2.

Yamashita, Kaoru, Satoshi Morimoto, Kanako Bokuda, et al.. (2023). Hyperuricemia and the Severity of Coronavirus Disease 2019 in Japan: A Retrospective Cohort Study – An Inseparable Relation with Hypertension and Chronic Kidney Disease. 7(2). 1 indexed citations

3.

Morimoto, Satoshi, Kanako Bokuda, Daisuke Watanabe, et al.. (2023). Effect of GH Deficiency Caused by Nonfunctioning Pituitary Masses on Serum C-reactive Protein Levels. Journal of the Endocrine Society. 7(12). bvad137–bvad137. 4 indexed citations

4.

Watanabe, Daisuke, Satoshi Morimoto, Noriko Morishima, & Atsuhiro Ichihara. (2023). Cardiovascular risk assessments in patients with cortisol-producing adenoma: impact of clinical features and genetic characteristics. Heart and Vessels. 39(1). 65–74.

5.

Yamaguchi, Takashi, Satoshi Morimoto, Atsuhiro Ichihara, et al.. (2023). Soluble (Pro)Renin Receptor Level in Patients with Severe Obesity Is Associated with Visceral Adiposity and Is Involved with Insulin Resistance and Renal Injury. Obesity Facts. 16(4). 335–343. 1 indexed citations

6.

Takagi, Kenjiro, Kazushi Watanabe, Kanji Tanaka, et al.. (2022). A Review of the Best Practice Guide 2021 for the Diagnosis and Management of Hypertensive Disorders of Pregnancy (HDP). 10(2). 57–73. 8 indexed citations

7.

Ichihara, Atsuhiro, et al.. (2022). Association between overweight and growth hormone secretion in patients with non-functioning pituitary tumors. PLoS ONE. 17(4). e0267324–e0267324. 3 indexed citations

8.

Morimoto, Satoshi, Takeshi Iida, Hidenobu Okuda, et al.. (2021). Serum soluble (pro)renin receptor level as a prognostic factor in patients undergoing maintenance hemodialysis. Scientific Reports. 11(1). 17402–17402. 3 indexed citations

9.

Morimoto, Satoshi, Noriko Morishima, Daisuke Watanabe, et al.. (2021). Immunohistochemistry for (Pro)renin Receptor in Humans. International Journal of Endocrinology. 2021. 1–9. 7 indexed citations

10.

Watanabe, Daisuke, Satoshi Morimoto, Noriko Morishima, et al.. (2020). Adrenal (Pro)renin Receptor Expression and Serum Soluble (Pro)renin Receptor Concentration in Primary Aldosteronism. International Journal of Endocrinology. 2020. 1–9. 8 indexed citations

11.

Wang, Fei, Xiaohan Lu, Kexin Peng, et al.. (2016). Antidiuretic Action of Collecting Duct (Pro)Renin Receptor Downstream of Vasopressin and PGE2 Receptor EP4. Journal of the American Society of Nephrology. 27(10). 3022–3034. 69 indexed citations

12.

Ramkumar, Nirupama, Deborah Stuart, Elena Mironova, et al.. (2016). Renal tubular epithelial cell prorenin receptor regulates blood pressure and sodium transport. American Journal of Physiology-Renal Physiology. 311(1). F186–F194. 51 indexed citations

13.

Ichihara, Atsuhiro. (2015). [Pathogenic mechanism of primary hypertension].. PubMed. 73(11). 1809–14. 4 indexed citations

14.

Okamoto, Takayuki, et al.. (2014). Visceral Fat Level Is an Independent Risk Factor for Cardiovascular Mortality in Hemodialysis Patients. American Journal of Nephrology. 39(2). 122–129. 25 indexed citations

15.

Ichihara, Atsuhiro, Yuki Kaneshiro, & Fumiaki Suzuki. (2006). Prorenin receptor blockers: effects on cardiovascular complications of diabetes and hypertension. Expert Opinion on Investigational Drugs. 15(10). 1137–1139. 32 indexed citations

16.

Hayashi, Masato, Y. Tsuchiya, Tomoyoshi Takenaka, et al.. (2004). Comparison of the effects of calcitriol and maxacalcitol on secondary hyperparathyroidism in patients on chronic haemodialysis: a randomized prospective multicentre trial. Nephrology Dialysis Transplantation. 19(8). 2067–2073. 28 indexed citations

17.

Ichihara, Atsuhiro, Matsuhiko Hayashi, Yuki Kaneshiro, et al.. (2004). Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle” region for nonproteolytic activation of prorenin. Journal of Clinical Investigation. 114(8). 1128–1135. 349 indexed citations

18.

Ichihara, Atsuhiro, Matsuhiko Hayashi, Yuki Kaneshiro, et al.. (2004). Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle” region for nonproteolytic activation of prorenin. Journal of Clinical Investigation. 114(8). 1128–1135. 41 indexed citations

19.

Ichihara, Atsuhiro, Matsuhiko Hayashi, Yukako Koura, Yuko Tada, & Takao Saruta. (2003). Intensive Blood-Pressure Lowering Effects on Arterial Wall Stiffness in Hypertensive Patients. Japanese Circulation Journal-english Edition. 67. 571. 10 indexed citations

20.

Ichihara, Atsuhiro. (2002). Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus. Nephrology Dialysis Transplantation. 17(8). 1513–1517. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact